Publications Groups Scientific Programs About Us
Harald StenmarkHåvard E. DanielsenKnut Liestøl Ragnhild A. LotheAntoni WiedlochaKirsten SandvigErlend B. Smeland
ProjectsUnit of Cellular Electron Microscopy Phosphatidylinositol signaling & diseaseCytokinesis in development and carcinogenesisMembrane-associated protein dynamics in cell divisionGroup membersKey achievementsPublications

We use the fruit fly, Drosophila melanogaster, as a genetic model system to investigate the relationship between cell signaling and intracellular vesicle trafficking pathways of importance in cancer and neurodegeneration.
The hallmarks of epithelial derived cancers include loss of epithelial organisation, uncontrolled proliferation, dysregulated cell death and metastasis. Vesicle-mediated trafficking pathways are necessary for correct execution of each of these processes. This is demonstrated by experiments where loss of molecular components regulating endocytosis leads to the loss of epithelial organisation, increased cell signalling, tumor-like growth and invasion in Drosophila. Importantly, this appears to be directly relevant to understand cancer as several of these molecular components also act as tumor suppressors in vertebrates. Defects in another vesicle mediated pathway, called autophagy, are also associated with cancer as well as neurodegenerative disease.
We primarily study the biological functions of the phosphatidylinositol kinases (PIKs) and their effectors that regulate endocytosis and autophagy with the aim to understand the molecular mechanisms regulating these processes and how their abnormal function contribute to cancer and neurodegeneration.
To investigate these issues, we have generated and obtained mutants of PIKs and effector proteins. We are currently studying the function of these genes using a combination of targeted gene expression, conditional knock out, RNAi mediated knock down, electron microscopy, immunofluorescence and confocal microscopy.


David Bilder, University of California, Berkeley, US
Jean Paul Vincent, MRC, Mill, London, UK
Ragnhild Lothe, Centre for Cancer Biomedicine, The Norwegian Radium Hospital, Oslo, Norway